tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Psychedelic: Compass Pathways, GH Research report Q3 earnings
PremiumThe FlyPsychedelic: Compass Pathways, GH Research report Q3 earnings
1M ago
ATAI Life Sciences Files Prospectus for Share Resale
Premium
Company Announcements
ATAI Life Sciences Files Prospectus for Share Resale
1M ago
ATAI Life Sciences Completes Acquisition of Beckley Psytech
Premium
Company Announcements
ATAI Life Sciences Completes Acquisition of Beckley Psytech
1M ago
Atai Life Sciences moved to Buy rating at Berenberg
PremiumThe FlyAtai Life Sciences moved to Buy rating at Berenberg
2M ago
Psychedelic: Clearmind enrolls last patient in first cohort of CMND-100 trial
Premium
The Fly
Psychedelic: Clearmind enrolls last patient in first cohort of CMND-100 trial
2M ago
Atai Life Sciences price target raised to $14 from $11 at Canaccord
Premium
The Fly
Atai Life Sciences price target raised to $14 from $11 at Canaccord
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100